Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)
Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
BMC Cancer
|
March 30, 2022
Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients
S K B Spohn, S Adebahr, M Huber, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 2, 2023
Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer
Julius C Holzschuh, Michael Mix, Juri Ruf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 23, 2025
Refining prognostic stratification in salvage radiotherapy for prostate cancer: a retrospective multicenter cohort study using PSMA-PET and machine learning
Federica Medici, Daniel M Aebersold, Jozefina Casuscelli, et al.
European Urology Focus
|
November 28, 2024
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following Prostatectomy
Constantinos Zamboglou, Paulina Staus, Martin Wolkewitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 6, 2025
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer
Gernot Ortner, Xenia Hoderlein, Francesco Barbato, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 8, 2024
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy
Sophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 12, 2026
PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomy
Sophia Scharl, Reinhard Thamm, Constantinos Zamboglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 28, 2024
Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis
Christian Trapp, Daniel M Aebersold, Claus Belka, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
Nantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)
Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
BMC Cancer
|
March 30, 2022
Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients
S K B Spohn, S Adebahr, M Huber, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 2, 2023
Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer
Julius C Holzschuh, Michael Mix, Juri Ruf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 23, 2025
Refining prognostic stratification in salvage radiotherapy for prostate cancer: a retrospective multicenter cohort study using PSMA-PET and machine learning
Federica Medici, Daniel M Aebersold, Jozefina Casuscelli, et al.
European Urology Focus
|
November 28, 2024
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following Prostatectomy
Constantinos Zamboglou, Paulina Staus, Martin Wolkewitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 6, 2025
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer
Gernot Ortner, Xenia Hoderlein, Francesco Barbato, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 8, 2024
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy
Sophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 12, 2026
PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomy
Sophia Scharl, Reinhard Thamm, Constantinos Zamboglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 28, 2024
Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis
Christian Trapp, Daniel M Aebersold, Claus Belka, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
Nantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.
Page
of 8